Globally, 1.2 billion people have no access to electricity. On the occasion of VELUX 75th anniversary the company decided to address this issue. Together with the social business Little Sun and the NGO Plan International they are collaborating to bring clean, reliable and affordable light to off-grid regions in Zambia, Sierra Leone and Zimbabwe.
14,500 Natural Light lamps from the VELUX Group have now arrived in Africa and the first recipients can already look forward to a better quality of life.
Among them are young girls between 10 and 18 years of age who live in a safe house in the slum area Mntendere in the Zambian capital Lusaka.
"The lamps mean the girls can do their homework when they get back from school and can feel safer at night, instead of huddling together in the dark after sunset. And it’s particularly important for our children that they feel safe – many are carrying the mental baggage such as the trauma of violence, rape or drugs," says safe house manager Verann Delarey.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7769151-velux-natural-light-and-life-zambia/
This candid, autobiographical book tells of Jay’s journey to find his identity and his own version of “happy” in early adulthood through self-destructive means like alcohol, a myriad of drugs, and other risky behavior, and how he pulled himself back from the edge of the abyss, finding the courage to live a life of clarity and purpose after discovering what true, lasting happiness in life is all about. Find out more at -http://www.amazon.com/Jerome-Jay-Isip/e/B00PB2P6SS/ref=ntt_dp_epwbk_1 Biography, Memoir, Self-Help
The Partnership for Drug-Free Kids, a national nonprofit dedicated to reducing substance abuse among adolescents, today launched a new multimedia campaign for teens that illustrates some of the pressures they face, including peer pressure to drink and use drugs, issues with body image and bullying, among others. The “Who Controls You” campaign breaks this month and was created pro-bono by advertising agency, Hill Holliday and award-winning, social media influencer, Maris Jones, as part of the Partnership’s Above the Influence (ATI) teen program.
“We are incredibly proud of this work. We struck gold when Hill Holliday collaborated with Adolescent Media and Maris Jones to bring this campaign to life,” said Chief Marketing Officer for the Partnership for Drug-Free Kids, Kristi Rowe. “Partnering with a young, talented social media influencer like Maris lent such a unique and authentic voice to this effort. Combining the extraordinary insight and passion of the Hill Holliday team with Maris’ distinct artistry brought an unexpected style to the campaign that makes this creative truly break through.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7103751-drug-free-partnership-who-controls-you/
A recent survey conducted by Harris Poll on behalf of the newly-formed Coalition to Prevent Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Misuse (CPAMM) finds that college students’ perceptions and attitudes towards the misuse, abuse and diversion of ADHD prescription stimulants are complex. The findings paint a portrait of students who recognize the risks of misuse, but understand why some students may choose to misuse, given the academic pressures in today’s college environment. CPAMM intends to use the findings to inform and develop educational campaigns to help prevent nonmedical use of ADHD prescription stimulants. The survey was conducted online between May 15 and June 11, 2014 among 2,056 US college students (full-time, 91%, part-time, 9%), defined as adults aged 18 to 24 enrolled and seeking a degree at a 4-year college or university and attending at least some in-person classes.1
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7373051-cpamm-survey-reveals-college-students-adhd-prescription-stimulant-abuse-misuse-and-diversion/
Nonfiction – This is a true account – a memoir – of a single mother losing everything, including her 2 children, Jayden and Annie, to a wretched alcohol and drug addiction; and ultimately losing herself. Yet through the storm, she finds the strength to overcome this addiction, as a result gaining more than ever before. “Freedom has never been sweeter.” Though her story starts out in despair, it ends on a positive note, providing hope to all those that read it. Learn more about this book here, http://alisamassey.com Inspirational Christian memoir about overcoming personal obstacles (drugs and alcohol).
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced at the mHealth Summit that it is expanding the beta program for its Patient Instructions feature, which enables physicians who use Medscape Mobile to securely send education and instructions on thousands of conditions, procedures and drugs to their patients who use the WebMD app for iPhone, or access WebMD on a PC or other mobile device. The company also previewed a forthcoming version of its WebMD app that leverages the 2net™ Platform from Qualcomm Life, Inc., a subsidiary of Qualcomm Incorporated (NASDAQ: QCOM), to enable health-conscious consumers to access and manage wireless health data from a wide array of fitness, wellness and medical devices directly from the app.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60050-webmd-accelerates-consumer-provider-connectivity-personalized-mobile-app
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management solutions, has announced the availability of an extensive set of advanced predictive sciences applications and services. These integrated capabilities enable drug discovery teams to investigate and evaluate hypotheses about the chemical or biological behavior of molecules of therapeutic interest in silico prior to costly experimentation. Accelrys predictive sciences leverages the open, scientifically aware Accelrys Enterprise Platform to deliver an advanced scientific decision support environment that reduces time and expense, improves quality, enhances collaboration and accelerates innovation in bringing new drugs to market.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62190-accelrys-offers-integrated-predictive-sciences-solutions-faster-innovation
